| Blood component therapy: Which, when and how much. | |
| | |
MedLine Citation:
|
PMID: 21772701 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Blood transfusion refers to the perioperative administration of blood and blood components. Adherence to proper indications for blood component therapy is essential because of its potential adverse effects and costs of transfusion. Over the years, the significance of blood components in treating certain diseases or conditions has been recognized. In this article, the most commonly used blood components along with the new developments in component therapy have been discussed. Recommendations by different academic and clinical trials and studies have been presented for quick reference. The individual coagulation factors are discussed in brief. |
| | |
Authors:
|
Rajesh Chand Arya; Gs Wander; Pankaj Gupta |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of anaesthesiology, clinical pharmacology Volume: 27 ISSN: 0970-9185 ISO Abbreviation: J Anaesthesiol Clin Pharmacol Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-07-20 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516972 Medline TA: J Anaesthesiol Clin Pharmacol Country: India |
Other Details:
|
Languages: eng Pagination: 278-84 Citation Subset: - |
Affiliation:
|
Department of Cardiac Anesthesiology, Hero DMC Heart Institute, Ludhiana. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Acute pulmonary edema after intramyometrial prostodin.
Next Document: T-helper cells in the etiopathogenesis of periodontal disease: A mini review.